Comorbidity of Myasthenia gravis and Graves' disease as immune reconstitution-associated autoimmune disease in HIV infection: A case report and literature review

HIV Med. 2024 Mar;25(3):398-403. doi: 10.1111/hiv.13584. Epub 2023 Nov 22.

Abstract

Background: Comorbidity of Myasthenia gravis (MG) and Graves' disease (GD) in treated HIV-infected individuals has rarely been described and little study has been done on the link between HIV-related immune reconstitution and autoimmune diseases occurring post antiretroviral therapy.

Case presentation: Here we report on a 33-year-old Chinese man with HIV infection who had been virologically suppressed since 2018. The patient was diagnosed with GD and was treated in 2020. Early in 2022, he developed fluctuating weakness and fatigue involving the bilateral extraocular muscles and limbs. With a positive neostigmine test, he was considered to have MG, but showed a poor response to oral medication. After multiple failed medication attempts, a thymectomy was finally performed to resolve his symptoms. The consecutive onset of immunological events may have partially resulted from immune reconstitution after viral control.

Conclusions: This is a rare case of HIV-related immune reconstitution-associated autoimmune disease (IRAD) with comorbidity of MG and GD which was reported initially. Cooperation with multidisciplinary teams is essential to avoid misdiagnosis and to promote the overall health of HIV-infected patients.

Keywords: ART; Graves' disease; HIV; immune reconstitution-associated autoimmune disease; myasthenia gravis.

Publication types

  • Review
  • Case Reports

MeSH terms

  • Adult
  • Comorbidity
  • Graves Disease* / complications
  • Graves Disease* / drug therapy
  • HIV Infections* / complications
  • HIV Infections* / drug therapy
  • Humans
  • Immune Reconstitution Inflammatory Syndrome*
  • Immune Reconstitution*
  • Male
  • Myasthenia Gravis* / complications
  • Myasthenia Gravis* / drug therapy